Patterns of nonadherence to antiepileptic drug therapy in children with newly diagnosed epilepsy.

CONTEXT Because of epilepsy's common occurrence, the narrow therapeutic and safety margins of antiepileptic medications, and the recognized complications of medication nonadherence in adults with epilepsy, identifying the rates, patterns, and predictors of nonadherence in children with epilepsy is imperative. The onset and evolution of antiepileptic drug nonadherence in children with newly diagnosed epilepsy remains unknown. OBJECTIVES To identify and characterize trajectories of adherence in children with newly diagnosed epilepsy over the first 6 months of therapy and to determine sociodemographic and epilepsy-specific predictors of adherence trajectories. DESIGN, SETTING, AND PATIENTS Prospective, longitudinal observational study of antiepileptic drug adherence in a consecutive cohort of 124 children (2-12 years old) with newly diagnosed epilepsy at Cincinnati Children's Hospital Medical Center. Patients were recruited from April 2006 through March 2009, and final data collection occurred in September 2009. MAIN OUTCOME MEASURE Objective adherence measured using electronic monitors. RESULTS Fifty-eight percent of children with newly diagnosed epilepsy demonstrated persistent nonadherence during the first 6 months of therapy. Group-based trajectory models identified 5 differential adherence patterns (Bayesian information criterion = -23611.8): severe early nonadherence (13%; 95% confidence interval [CI], 8%-20%), severe delayed nonadherence (7%; 95% CI, 3%-12%), moderate nonadherence (13%; 95% CI, 8%-20%), mild nonadherence (26%; 95% CI, 19%-34%), and near-perfect adherence (42%; 95% CI, 33%-50%). The adherence pattern of most patients was established by the first month of therapy. Socioeconomic status was the sole predictor of adherence trajectory group status (χ(4)(2) = 19.3 [n = 115]; P < .001; partial r(2) = 0.25), with lower socioeconomic status associated with higher nonadherence. CONCLUSION Five trajectory patterns were identified that captured the spectrum of nonadherence to antiepileptic drugs among children with newly diagnosed epilepsy; the patterns were significantly associated with socioeconomic status.

[1]  L. Lund Anticonvulsant effect of diphenylhydantoin relative to plasma levels. A prospective three-year study in ambulant patients with generalized epileptic seizures. , 1974, Archives of neurology.

[2]  D. Featherman,et al.  A revised socioeconomic index of occupational status , 1981 .

[3]  Daniel S Nagin,et al.  Group-based trajectory modeling in clinical research. , 2010, Annual review of clinical psychology.

[4]  L. Scheier,et al.  Adherence to Treatment in Children With Epilepsy: Who Follows "Doctor's Orders"? , 2000, Epilepsia.

[5]  R. Neville,et al.  What predicts poor collection of medication among children with asthma? A case-control study , 2002, European Respiratory Journal.

[6]  L. Kuller,et al.  Sudden and unexpected natural death in childhood and adolescence. , 1985, JAMA.

[7]  T. Glauser,et al.  Development and reliability of a correction factor for parent‐reported adherence to pediatric antiepileptic drug therapy , 2010, Epilepsia.

[8]  B. Fiese,et al.  Family asthma management routines: connections to medical adherence and quality of life. , 2005, The Journal of pediatrics.

[9]  G Koren,et al.  Critical Comparison of Novel and Existing Methods of Compliance Assessment During a Clinical Trial of an Oral Iron Chelator , 1994, Journal of clinical pharmacology.

[10]  J. Stockman Patterns of Nonadherence to Antiepileptic Drug Therapy in Children With Newly Diagnosed Epilepsy , 2012 .

[11]  M. Brodie,et al.  Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies , 2011 .

[12]  K. Stavem,et al.  Placebo‐corrected efficacy of modern antiepileptic drugs for refractory epilepsy: Systematic review and meta‐analysis , 2010, Epilepsia.

[13]  J. Portnoy,et al.  Pediatric asthma: a look at adherence from the patient and family perspective , 2004, Current allergy and asthma reports.

[14]  H. Kyngäs Compliance with health regimens of adolescents with epilepsy , 2000, Seizure.

[15]  A. Quittner,et al.  Barriers to treatment adherence for children with cystic fibrosis and asthma: what gets in the way? , 2006, Journal of pediatric psychology.

[16]  Christopher C. Cushing,et al.  Volitional and accidental nonadherence to pediatric inflammatory bowel disease treatment plans: initial investigation of associations with quality of life and disease activity. , 2010, Journal of pediatric psychology.

[17]  A. Quittner,et al.  Trajectories of adherence to airway clearance therapy for patients with cystic fibrosis. , 2010, Journal of pediatric psychology.

[18]  Tracy Glauser,et al.  ILAE Treatment Guidelines: Evidence‐based Analysis of Antiepileptic Drug Efficacy and Effectiveness as Initial Monotherapy for Epileptic Seizures and Syndromes , 2006, Epilepsia.

[19]  Jacob Cohen,et al.  Applied multiple regression/correlation analysis for the behavioral sciences , 1979 .

[20]  M. Morrell Brain stimulation for epilepsy: can scheduled or responsive neurostimulation stop seizures? , 2006, Current opinion in neurology.

[21]  S. Al-Aqeel,et al.  Strategies for improving adherence to antiepileptic drug treatment in patients with epilepsy. , 2011, The Cochrane database of systematic reviews.

[22]  Shelagh A. Mulvaney,et al.  Trajectories of symptoms and impairment for pediatric patients with functional abdominal pain: a 5-year longitudinal study. , 2006, Journal of the American Academy of Child and Adolescent Psychiatry.

[23]  S. Candrilli,et al.  Association of antiepileptic drug nonadherence with risk of seizures in adults with epilepsy , 2009, Epilepsy & Behavior.

[24]  D. Spencer,et al.  Practice parameter: Temporal lobe and localized neocortical resections for epilepsy: Report of the Quality Standards Subcommittee of the American Academy of Neurology, in Association with the American Epilepsy Society and the American Association of Neurological Surgeons , 2003, Neurology.

[25]  D. Sackett,et al.  IMPROVEMENT OF MEDICATION COMPLIANCE IN UNCONTROLLED HYPERTENSION , 1976, The Lancet.

[26]  C. Rand,et al.  Electronic Monitoring of Medication Adherence: When Is High-Tech Best? , 2002, Journal of Clinical Psychology in Medical Settings.

[27]  J. Portnoy,et al.  Volitional nonadherence in pediatric asthma: Parental report of motivating factors , 2007, Current allergy and asthma reports.

[28]  D. Schwebel,et al.  Pediatric Unintentional Injury: Behavioral Risk Factors and Implications for Prevention , 2007, Journal of developmental and behavioral pediatrics : JDBP.

[29]  J. Wheless,et al.  Adolescent and Caregiver Experiences With Epilepsy , 2009, Journal of child neurology.

[30]  Charles W. Mueller,et al.  Measures of socioeconomic status: Alternatives and recommendations. , 1981 .

[31]  Sydney S Cash,et al.  From ion channels to complex networks: magic bullet versus magic shotgun approaches to anticonvulsant pharmacotherapy. , 2009, Medical hypotheses.

[32]  J E Leestma,et al.  A prospective study on sudden unexpected death in epilepsy , 1989, Annals of neurology.

[33]  I. Litt,et al.  Adolescent non‐adherence: Prevalence and consequences in liver transplant recipients , 2006, Pediatric transplantation.

[34]  D. Drotar,et al.  Meta-analysis of psychological interventions to promote adherence to treatment in pediatric chronic health conditions. , 2008, Journal of pediatric psychology.

[35]  T. Glauser,et al.  Development and validation of the Pediatric Epilepsy Medication Self-Management Questionnaire , 2010, Epilepsy & Behavior.

[36]  H. Günthard,et al.  Longitudinal Analysis of Patterns and Predictors of Changes in Self-Reported Adherence to Antiretroviral Therapy: Swiss HIV Cohort Study , 2009, Journal of acquired immune deficiency syndromes.

[37]  J. Rausch,et al.  Treatment factors affecting longitudinal quality of life in new onset pediatric epilepsy. , 2011, Journal of pediatric psychology.

[38]  G. Tognoni,et al.  Pattern of diagnostic and therapeutic care of childhood epilepsy in Alexandria, Egypt. , 2002, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[39]  N. Nagelkerke,et al.  A note on a general definition of the coefficient of determination , 1991 .

[40]  Steve S. Chung,et al.  Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy , 2010, Epilepsia.

[41]  A. Asadi-Pooya Drug compliance of children and adolescents with epilepsy , 2005, Seizure.

[42]  S. Candrilli,et al.  Prevalence and cost of nonadherence to antiepileptic drugs in elderly patients with epilepsy , 2009, Epilepsy & Behavior.

[43]  R. Hays,et al.  A Comparison Study of Multiple Measures of Adherence to HIV Protease Inhibitors , 2001, Annals of Internal Medicine.

[44]  T. Glauser,et al.  One-Month Adherence in Children With New-Onset Epilepsy: White-Coat Compliance Does Not Occur , 2008, Pediatrics.

[45]  M. Salih,et al.  Compliance with appointments and medications in a pediatric neurology clinic at a University Hospital in Riyadh, Saudi Arabia. , 2002, Saudi medical journal.

[46]  A. Pai,et al.  The Allocation of Treatment Responsibility scale: A novel tool for assessing patient and caregiver management of pediatric medical treatment regimens , 2010, Pediatric transplantation.

[47]  E. Faught,et al.  Nonadherence to antiepileptic drugs and increased mortality , 2008, Neurology.

[48]  G. Mathern,et al.  Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies , 2009, Epilepsia.

[49]  D. Nagin Group-based modeling of development , 2005 .

[50]  M. Marcus,et al.  The return to smoking: 1-year relapse trajectories among female smokers. , 2005, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[51]  A. Modi,et al.  Barriers to Treatment Adherence for Pediatric Patients With Sickle Cell Disease and Their Families , 2009 .